2m 2m 2m 2m 2m 2m 2m
PASITHEA THERAP (KTTA)
NASDAQ
$0.52-$0.02 (-4.52%)
Price as of Aug 21, 2026 7:29 PM EDT- $18.0MMarket Cap
- -24.78%1-Year Change
- BiotechnologyIndustry
PASITHEA THERAP (KTTA)
$0.52-$0.02 (-4.52%)
KTTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | +$0.07 (+14.77%) | ||
Open | $0.49 | ||
High | $0.54 | ||
Low | $0.48 | ||
Previous Close | $0.47 | ||
Volume | 302,673 | ||
30-Day Average Volume | 243,072 | ||
1-Week Change | 12.26% | ||
1-Month Change | 18.60% | ||
1-Year Change | -24.78% | ||
3-Year Change | -95.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $51.7M | ||
Market Cap | $18.0M | ||
Enterprise Value | -$27.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $46.4M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 01/02/2024 | ||
Earnings & Revenue